1. Home
  2. BIVI vs LIQT Comparison

BIVI vs LIQT Comparison

Compare BIVI & LIQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIVI
  • LIQT
  • Stock Information
  • Founded
  • BIVI 2013
  • LIQT 2004
  • Country
  • BIVI United States
  • LIQT Denmark
  • Employees
  • BIVI N/A
  • LIQT N/A
  • Industry
  • BIVI Biotechnology: Pharmaceutical Preparations
  • LIQT Industrial Machinery/Components
  • Sector
  • BIVI Health Care
  • LIQT Technology
  • Exchange
  • BIVI Nasdaq
  • LIQT Nasdaq
  • Market Cap
  • BIVI 18.8M
  • LIQT 16.9M
  • IPO Year
  • BIVI N/A
  • LIQT N/A
  • Fundamental
  • Price
  • BIVI $0.85
  • LIQT $1.56
  • Analyst Decision
  • BIVI Strong Buy
  • LIQT Strong Buy
  • Analyst Count
  • BIVI 1
  • LIQT 2
  • Target Price
  • BIVI $30.00
  • LIQT $4.70
  • AVG Volume (30 Days)
  • BIVI 204.2K
  • LIQT 8.9K
  • Earning Date
  • BIVI 05-13-2025
  • LIQT 05-13-2025
  • Dividend Yield
  • BIVI N/A
  • LIQT N/A
  • EPS Growth
  • BIVI N/A
  • LIQT N/A
  • EPS
  • BIVI N/A
  • LIQT N/A
  • Revenue
  • BIVI N/A
  • LIQT $14,604,618.00
  • Revenue This Year
  • BIVI N/A
  • LIQT $33.40
  • Revenue Next Year
  • BIVI N/A
  • LIQT $47.64
  • P/E Ratio
  • BIVI N/A
  • LIQT N/A
  • Revenue Growth
  • BIVI N/A
  • LIQT N/A
  • 52 Week Low
  • BIVI $0.62
  • LIQT $1.34
  • 52 Week High
  • BIVI $7.50
  • LIQT $3.20
  • Technical
  • Relative Strength Index (RSI)
  • BIVI 43.28
  • LIQT 50.51
  • Support Level
  • BIVI $0.75
  • LIQT $1.46
  • Resistance Level
  • BIVI $0.88
  • LIQT $1.74
  • Average True Range (ATR)
  • BIVI 0.11
  • LIQT 0.11
  • MACD
  • BIVI 0.02
  • LIQT -0.00
  • Stochastic Oscillator
  • BIVI 81.78
  • LIQT 34.48

About BIVI BioVie Inc.

BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The Company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.

About LIQT LiqTech International Inc.

LiqTech International Inc is a clean technology company which provides technology for gas and liquid purification by manufacturing ceramic silicon carbide filters. The company is engaged in three businesses that are diesel particulate filters (DPF) for the control of soot from diesel engines, turnkey ceramic membranes systems, and complete water treatment plants. The company's product portfolio consists of ceramic silicon membranes for liquid filtration, diesel particulate filters, and kiln furniture. Its operating segment includes Water, Ceramics, and Plastics.

Share on Social Networks: